Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASCO 2022 | Challenges in managing small bowel tumors

Karan Pandya • 5 Jun 2022
ASCO 2022
Colorectal Cancer Gastrointestinal Cancer

Karan Pandya, MD, Rutgers University, New Brunswick, NJ, reflects on sampling small bowel tumors, highlighting its low incidence and associated challenges such as clinical trial enrollment. This interview took place at the American Society of Clinical Oncology (ASCO) 2022 Annual Meeting in Chicago, IL.

More from Karan Pandya

1:32
Areas of unmet need for small bowel adenocarcinoma
Karan Pandya • 5 Jun 2022
3:17
Genomic and transcriptomic characterization of small bowel adenocarcinoma
Karan Pandya • 5 Jun 2022

Related Videos

0:52
DRP-104 with durvalumab in fibrolamellar hepatocellular carcinoma
Marina Baretti • 9 Apr 2024
1:06
The emerging role of cancer vaccines in treating liver cancer
Marina Baretti • 9 Apr 2024
1:33
Peptide vaccines with ICIs for fibrolamellar hepatocellular carcinoma
Marina Baretti • 9 Apr 2024
4:12
PETRA: saruparib in solid tumors with BRCA1/2, PALB2 or RAD51C/D mutations
Timothy Yap • 7 Apr 2024
The content of VJOncology is intended for healthcare professionals